BG 777

Drug Profile

BG 777

Alternative Names: BG-777

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator Virocell
  • Class Antiretrovirals
  • Mechanism of Action Immunomodulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Bacterial infections; Coronavirus infections; Cytomegalovirus infections; HIV-1 infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Coronavirus-infections in Canada (IV)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in Cytomegalovirus infections in Canada (IV-infusion)
  • 16 Jul 2016 No recent reports of development identified for phase-I development in HIV-1-infections in Canada (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top